Inverse correlation between metallothioneins and hypoxia-inducible factor 1 alpha in colonocytes and experimental colitis

Biochemical and Biophysical Research Communications

Volumn 416, Issue 3-4, 2011, Pages 307-312

  Devisscher, Lindsey ^a   Hindryckx, Pieter ^a   Olievier, Kim ^a   Peeters, Harald ^a   De Vos, Martine ^a   Laukens, Debby ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Dimethyloxalylglycine; Experimental colitis; Hypoxia inducible factor; Hypoxic response; Inflammatory bowel disease; Metallothionein

Indexed keywords

DEXTRAN SULFATE; GLYCINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; METALLOTHIONEIN; OXYGENASE; SMALL INTERFERING RNA; VASCULOTROPIN; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AMINO ACIDS, DICARBOXYLIC; ANIMALS; COLITIS; COLON; DOWN-REGULATION; HT29 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATORY BOWEL DISEASES; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZINC;

MUS;

EID: 84855889289     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.031     Document Type: Article

References (28)

1. Inoue K., Takano H., Shimada A., Satoh M. Metallothionein as an anti-inflammatory mediator. Mediators of Inflammation 2009, 2009:101659.
2. Laukens D., Waeytens A., De Bleser P., Cuvelier C., De Vos M. Human metallothionein expression under normal and pathological conditions: mechanisms of gene regulation based on in silico promoter analysis. Critical Reviews in Eukaryotic Gene Expression 2009, 19:301-317.
3. Murphy B.J., Laderoute K.R., Chin R.J., Sutherland R.M. Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Research 1994, 54:5808-5810.
4. Yamasaki M., Nomura T., Sato F., Mimata H. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells. Oncology Report 2007, 18:1145-1153.
5. Thiersch M., Raffelsberger W., Frigg R., Samardzija M., Wenzel A., Poch O., Grimm C. Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection. BMC Genomics 2008, 8:73.
6. Wang B., Wood I.S., Trayhurn P. PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes. Biochemical and Biophysical Research Communications 2008, 368:88-93.
7. Jeng S.Y., Wu S.M., Lee J.D. Cadmium accumulation and metallothionein overexpression in internal spermatic vein of patients with varicocele. Urology 2009, 73:1231-1235.
8. Kojima I., Tanaka T., Inagi R., Nishi H., Aburatani H., Kato H., Miyata T., Fujita T., Nangaku M. Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidney. Kidney International 2009, 75:268-277.
9. Li X., Chen H., Epstein P.N. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. Journal of Biological Chemistry 2004, 279:765-771.
10. Wang G.W., Zhou Z., Klein J.B., Kang Y.J. Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:2292-2299.
11. Kim H.G., Hwang Y.P., Jeong H.G. Metallothionein-III induces HIF-1α-mediated VEGF expression in brain endothelial cells. Biochemical and Biophysical Research Communications 2008, 369:666-671.
12. Kang Y.J., Li G., Saari J.T. Metallothionein inhibits ischemia-reperfusion injury in mouse heart. American Journal of Physiology 1999, 276:993-997.
13. Kang Y.J., Li Y., Sun X. Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice. American Journal of Pathology 2003, 163:1579-1586.
14. Semenza G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Current Opinion in Genetics and Development 1998, 8:588-594.
15. Feng W., Wang Y., Cai L., Kang Y.J. Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytes under diabetic conditions. Biochemical and Biophysical Research Communications 2007, 360:286-289.
16. Giatromanolaki A., Sivridis E., Maltezos E., Papazoglo D., Simopoulos C., Gatter K.C., Harris A.L., Koukourakis M.I. Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease. Journal of Clinical Pathology 2003, 56:209-213.
17. Karhausen J., Furuta G.T., Tomaszewski J.E., Johnson R.S., Colgan S.P., Haase V.H. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. Journal of Clinical Investigation 2004, 114:1098-1106.
18. Hindryckx P., De Vos M., Jacques P., Ferdinande L., Peeters H., Olievier K., Brinkman B., Vandenabeele P., Elewaut D., Laukens D. Hydroxylase inhibition abrogates TNF-α-induced intestinal epithelial damage by HIF-1-dependent repression of Fas-associated death domain. Journal of Immunology 2010, 6306-6316.
19. Taylor C.T., Colgan S.P. Hypoxia and gastrointestinal disease. Journal of Molecular Medicine 2007, 85:1295-1300.
20. Cummins E.P., Seeballuck F., Keely S.J., Mangan N.E., Callanan J.J., Fallon P.G., Taylor C.T. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 2008, 134:156-165.
21. Rana B., Mischoulon D., Xie Y., Bucher N.L., Farmer S.R. Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors. Molecular and Cellular Biology 1994, 5858-5869.
22. Choy S.M., Choi K.O., Lee N., Oh M., Park H. The zinc chelator, N, N, N', N'-tetrakis (2-pyridylmethyl) ethylenediamine, increases the level of nonfunctional HIF-1α protein in normoxic cells. Biochemical and Biophysical Research Communications 2006, 343:1002-1008.
23. Yin X., Knecht D.A., Lynes M.A. Metallothionein mediates leucocyte chemotaxis. BMC Immunology 2005, 6:21.
24. Waeytens A., De Vos M., Laukens D. Evidence for a potential role of metallothioneins in inflammatory bowel diseases. Mediators Inflammation 2009, 2009:729172.
25. Taylor C.T. Regulation of intestinal epithelial gene expression in hypoxia. Kidney International 2004, 66:528-531.
26. Robinson A., Keely S., Karhausen J., Gerich M.E., Furuta G.T., Colgan S.P. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 2008, 134:145-155.
27. Oz H.S., Chen T., de Villiers W.J., McClain C.J. Metallothionein overexpression does not protect against inflammatory bowel disease in a murine colitis model. Medical Science Monitor 2005, 11:69-73.
28. Tran C.D., Ball J.M., Sundar S., Coyle P., Howarth G.S. The role of zinc and metallothionein in the dextran sulfate sodium-induced colitis mouse model. Digestive Diseases and Sciences 2007, 52:2113-2121.